The first member of the bisphosphonate family of bone therapies for preventing or treating osteoporosis. It prevents spine fractures. The active medicine is only taken for the first two weeks of every three months. It is less expensive, has fewer side effects and is easier to take than newer bisphosphonates. It can be taken in the middle of the night. OR an early biphosphanate taken for two weeks, every three months. Prevents spine fractures in randomized placebo-controlled trials. Does not cause heartburn or esophageal injury. See bisphosphonates.
Explore All Resources
-
The ABCs of Osteoporosis Prevention for Premenopausal Women
Cyclic Progesterone TherapyDiet -
The ABCs of Osteoporosis Prevention for Teenage Women
Cyclic Progesterone TherapyDiet -
The ABCs Of Osteoporosis Prevention For Menopausal Women
Daily Progesterone therapyDiet -
Depo-Provera Use and Bone Health
Contraception / Birth ControlCyclic Progesterone Therapy -
Do Fibroids Cause Heavy Flow in Perimenopause?
Common Menstrual ConcernsEndometrial cancer -
The ABCs of Osteoporosis Prevention for Men with Prostate Cancer on Testosterone-Lowering Treatment
DietHealth Issues -
Progesterone is NOT a Progestogen/Progestin— It’s Estrogen’s Unique Biological Partner
Breast cancerCyclic Progesterone Therapy
Glossary
Visit the Glossary to learn more about the specific terms used on this website.
-
Etidronate
-
T-Score
The term used to describe standard deviations below the average in healthy premenopausal women ages 20-30 in the population as measured by bone mineral density. OR the term used to decide whether bone mineral density is normal, low (osteopenia) or suggests a strong risk for fragility fracture, called osteoporosis. Is based on the bell shaped curve distribution of bone density from a random sample of men or women ages 20-30.
More Than One Way to Support Us!
Make a direct donation to CeMCOR’s Research Fund or purchase the Estrogen’s Storm Season book.
All royalties from book sales go directly to the CeMCOR Endowment Fund.